Category 2 Key clinical evidence Sermorelin FDA-era pediatric trials + PK data Tesamorelin Phase 3 visceral fat data CJC-1295 (DAC) Phase 1 PK and GH/IGF-1 duration data Typical research dose Sermorelin 200-300 mcg nightly Tesamorelin 2 mg daily CJC-1295 (DAC) 1-2 mg weekly Main use case Sermorelin GH optimization, sleep, recovery Tesamorelin Visceral fat / metabolic context CJC-1295 (DAC) Sustained GH/IGF-1 elevation All three target the same receptor but are not interchangeable
Together, they support body recomposition, meaning fat loss with muscle maintenance or even gain
Summary: B12 and lipo shots combine vitamin B12 injections with lipotropic compounds, but only B12 injections are licensed NHS medicines for treating confirmed deficiency, whilst lipotropic injections lack MHRA approval and clinical evidence
Injections bypass digestion and may allow for greater systemic exposure, making them the more common route for localized tissue and recovery goals
Patients taking warfarin, heparin, DOACs (direct oral anticoagulants), or high-dose aspirin should discuss potential interactions with their provider before starting BPC-157
The researchers concluded that AHK-Cu promotes hair growth through a dual mechanism, stimulating cell multiplication while preventing cell death
